Literature DB >> 21687938

Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells.

Eiichi Sakurai1, Chihaya Maesawa, Masahiko Shibazaki, Shinji Yasuhira, Hiroki Oikawa, Masayuki Sato, Kanako Tsunoda, Yuichi Ishikawa, Ayano Watanabe, Kazuhiro Takahashi, Toshihide Akasaka, Tomoyuki Masuda.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs whose aberrations are involved in the initiation and progression of human cancers. To seek unique miRNAs contributing to melanoma tumorigenesis, we investigated the global miRNA expression profile of 7 melanoma cell lines and 3 primary cultures of neonatal human epidermal melanocytes (NHEMs) using the stem-loop real-time PCR method. We found 7 miRNAs that were commonly downregulated and 18 that were upregulated in all of the melanoma cell lines in comparison with the 3 primary cultures of NHEMs. We focused on one commonly downregulated miRNA (miR-211), and analyzed its relationship to the expression of preferentially expressed antigen of melanoma (PRAME) protein, which is a potential target of miR-211. We found that all melanoma cell lines exhibited marked down--regulation of miR-211 and upregulation of PRAME mRNA/protein expression in comparison with NHEMs (P<0.05). A significant inverse correlation between miR-211 and PRAME protein expression was found in melanoma cell lines and primary cultures of NHEMs (correlation coefficient of -0.733, P<0.05). We demonstrated that overexpression of miR-211 induced a reduction of PRAME protein levels, and confirmed the target specificity between miR-211 and PRAME by luciferase reporter assay. These results suggest that downregulation of miR-211 may be partly involved in aberrant expression of the PRAME protein in melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21687938     DOI: 10.3892/ijo.2011.1084

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  19 in total

Review 1.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

2.  Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.

Authors:  Lei Wang; Yan-Feng Shen; Zhi-Min Shi; Xiao-Juan Shang; Dong-Ling Jin; Feng Xi
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

3.  MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration.

Authors:  Guo-qing Song; Yi Zhao
Journal:  Tumour Biol       Date:  2015-02-14

4.  MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma Cells.

Authors:  Joseph Mazar; Feng Qi; Bongyong Lee; John Marchica; Subramaniam Govindarajan; John Shelley; Jian-Liang Li; Animesh Ray; Ranjan J Perera
Journal:  Mol Cell Biol       Date:  2016-01-19       Impact factor: 4.272

5.  MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.

Authors:  Jun Zhang; Jianguang Lv; Feng Zhang; Hongmin Che; Qiwei Liao; Wobin Huang; Shaopeng Li; Yuqian Li
Journal:  J Neurooncol       Date:  2017-05-27       Impact factor: 4.130

6.  MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.

Authors:  Ahmet Taner Sümbül; Bülent Göğebakan; Süleyman Bayram; Celal Yücel Batmacı; Serdar Öztuzcu
Journal:  Tumour Biol       Date:  2015-07-08

7.  Regulation of PP2Cm expression by miRNA-204/211 and miRNA-22 in mouse and human cells.

Authors:  Bang-fen Pan; Chen Gao; Shu-xun Ren; Yi-bin Wang; Hai-peng Sun; Mei-yi Zhou
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

8.  Diagnostic marker signature for esophageal cancer from transcriptome analysis.

Authors:  Ute Warnecke-Eberz; Ralf Metzger; Arnulf H Hölscher; Uta Drebber; Elfriede Bollschweiler
Journal:  Tumour Biol       Date:  2015-12-02

Review 9.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

10.  Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties.

Authors:  Yuanhua Liu; Valentina Devescovi; Suning Chen; Christine Nardini
Journal:  BMC Syst Biol       Date:  2013-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.